53/100Is NBIS-Nebius Group N.V. a buy?
Wednesday 8 July 2026
Why now: The stock is in a deep pullback, but the underlying demand narrative for AI compute is still intact and the company has recently reported very fast revenue growth. This is a “watch and be ready” moment for long-term investors who want exposure to AI infrastructure but need proof the stock can stabilize.
Upside: If NBIS can rebuild confidence with clean execution and financing clarity, a return toward the prior resistance area near $300 would imply roughly 50% upside from $195.13. Longer term, the upside depends on turning large customer commitments into sustained revenue and cash flow.
Risks: The biggest risks are execution delays in bringing capacity online and financing or dilution risk from very high capital spending plans. A second risk is customer concentration, where a small number of very large contracts can dominate results.
Scorecard
| Scorecard | 53/100 | |
|---|---|---|
| Company Detail | NBIS - Nebius Group N.V. | |
| Price as at 7 July 2026 | $195.19 | |
| Market cap | $49.6B | |
| Quality and Fundamental Score (100) | ||
| Breakout / Early-Momentum /20 | 0/20 | |
| Rev/EPS Momentum /20 | 18/20 | |
| Business Quality /15 | 11/15 | |
| Balance Sheet /15 | 10/15 | |
| Valuation /10 | 4/10 | |
| Industry Relative Strength /10 | 7/10 | |
| Macro / Sector Tailwind /10 | 3/10 | |
| Growth (mechanical) | ||
| Cash runway | 2.5 yr | |
| Revenue YoY | +479.0% | |
| EPS YoY | +114.7% | |
| FCF YoY | -555.1% | |
| Gross margin | 68.6% | |
| Valuation & Trend | ||
| Trailing P/E | 75.1x | |
| Forward P/E | 540.4x | |
| RSI (14d) | 39 | |
| vs 50d SMA | -10.0% | |
| Support cushion | −32.0% | |
| Sentiment | ||
| Wall Street verdict | Mixed | |
| News tone | Mixed | |
| Dividend | — | |
How are these colored?
| Metric | Strong metrics | Solid metrics | Selective | Caution | Unfavourable |
|---|---|---|---|---|---|
| Overall score | ≥ 80 | 70-79 | 60-69 | 50-59 | < 50 |
| Business quality /15 | ≥ 12 | 10-11 | 8-9 | 6-7 | < 6 |
| Balance sheet /15 | ≥ 12 | 10-11 | 8-9 | 6-7 | < 6 |
| Market cap | ≥ $20B | $5B-$20B | $2B-$5B | $1B-$2B | < $1B |
| Cash runway | ≥ 3 yr or cash generative | 1.5-3 yr | 0.75-1.5 yr | 0.25-0.75 yr | < 0.25 yr |
| Revenue YoY | ≥ 15% | 5-15% | 0-5% | -5-0% | < -5% |
| EPS YoY | ≥ 20% | 5-20% | 0-5% | -5-0% | < -5% |
| FCF YoY | ≥ 10% | 1-10% | 0-1% | -5-0% | < -5% |
| Gross margin | ≥ 60% | 40-60% | 25-40% | 10-25% | < 10% |
| Trailing P/E | < 15 | 15-25 | 25-35 | 35-40 | > 40 or neg |
| Forward P/E | < 15 | 15-25 | 25-35 | 35-40 | > 40 or neg |
| RSI (14d) | 50-70 | 45-50 or 70-75 | 40-45 or 75-78 | 30-40 or 78-80 | < 30 or > 80 |
| vs 50d SMA | +2% to +15% | 0-2% or 15-25% | -2-0% or 25-35% | -3--2% or 35-40% | < -3% or > 40% |
| Support cushion | 2-10% above | 0-2% | 10-15% | 15-20% | price below support |
| Wall Street verdict | Aligned | — | Mixed | — | Disagrees |
| News tone | Positive | — | Neutral / Mixed | — | Negative |
| Dividend | Yield ≥ 2% & growing | Growing | Flat payer ≥ 1% | Low / flat | Cutting |
Detailed Analysis — Wednesday 8 July 2026
Arkady Volozh has been Chief Executive Officer since August 2024.
Maria del Dado Alonso Sanchez has been Chief Financial Officer since June 2025.
- Nebius is a direct play on the AI compute build-out, and recent reported growth shows it is capturing real demand.
- The investment case rests on scaling contracted capacity into steady revenue while keeping funding costs and dilution under control.
- The setup is not currently friendly, so the right approach is patience until execution and the stock both re-stabilize.
Show 5 headlines from the last 7d
Scores 53 out of 100 — a mixed overall grade. Earnings trend and business quality scored highest. Relative strength versus its industry and balance sheet were fair but not standout drivers. Valuation and sector fit weighed on the total. The long-term story is strong, but the current chart is weak versus the 50-day moving average and far below the prior resistance level, so the momentum setup is not ready. The company is also extremely capital intensive, which raises dilution and execution risk and keeps the score from being higher even with rapid growth.
Component scores are on the scorecard above.
- Technically, NBIS is not in a healthy accumulation phase right now.
- It is below its 50-day moving average and has not reclaimed it recently, it is well below the prior resistance level, and the short-term trend has been down even though the longer-term trend remains up with a rising 200-day moving average.
- The one constructive point is that it still shows strong longer-term performance and strong industry-relative behavior, but the current tape says buyers have stepped back.
- The company reported a sharp step-up in Q1 2026 revenue growth year over year and improved adjusted profitability versus the prior year, which supports the view that demand is real and scaling.
- It also reported a very large cash balance at quarter end, helped by financing and customer prepayments, which is important for a capital-heavy build-out.
- Red flags are also clear: the business has very high capital spending needs, and results can be distorted by financing, prepayments, and accounting items; investors should focus on repeatable operating cash generation and utilization as capacity ramps.
- Another key risk is concentration in very large customers and contracts, which can make revenue and margins lumpy if timelines change.
Cash runway: 2.5 yr ($9.3B cash ÷ $3.7B/yr burn, latest fiscal year).
Upcoming (1–6 months)
- The next quarterly earnings update and management commentary on capacity activation and funding plan over the next 1 to 2 quarters.
Ongoing
- Progress on bringing new capacity online and whether utilization and margins hold up as depreciation and interest costs rise with the build-out.
Risks
- Very high capital spending requirements can force repeated dilution or expensive financing if market conditions tighten.
- Customer concentration and delivery timing risk can create sudden revenue or margin shocks if a major contract is delayed, resized, or repriced.
Breaks the thesis
- If the company reports material slippage in capacity ramp or a clear deterioration in demand signals, treat the long-term thesis as broken regardless of short-term stock moves.
